group-icon

Focus LIVE! Upcoming Webinars

Earn MOC self-assessment CME and test your knowledge with live and interactive sessions covering important topics in psychiatry.

Moderating both Focus LIVE! events is Mark Hyman Rapaport, M.D. | View Bio

June
2020
03

Evidence-Based Principles for Bipolar Disorder Treatment

  • Wednesday, June 3, 2020
  • 7:30 – 9:00 p.m. ET
  • Joseph Goldberg, M.D. | View Bio
  • Free Registration
Course Description

In the more than quarter-century since Guyatt coined the term evidence-based medicine, the concept has evolved to describe medical treatments that not only strive to merge high-quality research findings with practitioners’ own observations but also reflect awareness of the best available evidence, define the trustworthiness of that evidence, and incorporate patient values and preferences for deciding among treatment risks, benefits, and costs. In the world of bipolar disorder, the practice guidelines, review papers, and educators tend to identify evidence-based treatments along the lines of specific illness phases or within other narrow contexts—treatment of bipolar depression, maintenance pharmacotherapy, rapid cycling, bipolar II disorder, or adjunctive psychotherapy—to prevent relapse or improve quality of life.

This FOCUS LIVE presentation will present multiple choice polls based on information about the current status of our treatment approaches for bipolar disorders and will provide participants with an opportunity to test their knowledge about this disorder.

To view faculty and planner disclosures, please visit http://APAPsy.ch/FocusLive201

Learning Objectives
  • Review approaches to evidence-based principles for bipolar disorder treatment and be better able to make informed decisions in the clinical setting.
  • Review current knowledge, recognize gaps in learning, and identify areas where more study is needed to enhance the management of patients' treatment.

 

June
2020
10

Biomarkers in Psychiatry

  • Wednesday, June 10, 2020
  • 7:30 – 9:00 p.m. ET
  • John Rush, M.D. | View Bio
  • Free Registration
Course Description

The future of psychiatry will entail the development and application of biomarkers in nearly every aspect of practice, including rendering a diagnosis and a differential diagnosis, selecting appropriate treatments, predicting and perhaps preventing adverse treatment effects, personalizing dose titration schedules as well as multi-step treatment programs, and predicting—if not preventing—relapses. Biomarkers will help us measure disease progression and resolution, taking us far beyond symptom rating scales to gauge how we are helping patients.

This FOCUS LIVE presentation will present multiple choice poll questions based on information about the current status of our treatment approaches involving use of biomarkers.

To view faculty and planner disclosures, please visit http://APAPsy.ch/FocusLive202

Learning Objectives
  • Acknowledge the complexities of the identification and application of biomarkers in psychiatry from both clinical and etiological perspectives.
  • Acknowledge the value that biomarkers may bring to clinical practice and clinical decision making in conditions such as autism, PTSD, schizophrenia, dementia, and sleep-wake disorders.
  • Review current knowledge, recognize gaps in learning, and identify areas where more study is needed to enhance management of patients’ treatment.

Register Today


Upon completion of the activity, instructions for claiming CME and Self-assessment credit (MOC 2) will be provided to participants. Participants will be able to claim two AMA PRA Category 1 Credits™ and two MOC Part 2 self-assessment questions for each activity. Due to the interactive nature of this event, this event will only be offered live and will not be recorded. Participation is limited to the first 950 participants who register. There is no cost to attend this event or to earn CME credit. APA is making this meeting available to its members as a benefit of APA membership. For ABPN diplomates, access to this program was supported through an unrestricted grant from the American Board of Psychiatry and Neurology.

Accreditation: The American Psychiatry Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation: The APA designates each of these live activities for a maximum of 2 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.